Table 2. Health care–associated... | American Society of Hematology

Table 2.

Health care–associated infections in patients without diabetes

Outcome measures	TXA (n = 204)	Placebo (n = 200)	RR (95% CI)	P
Primary end point
Health care–associated infection	43 (21.1)	63 (31.5)	0.67 (0.48-0.94)	.017
Secondary end points*	23 (11.3)	22 (11.0)	1.03 (0.59-1.78)	.93
Pneumonia
SSI	22 (10.8)	36 (18.0)	0.60 (0.37-0.98)	.039
Superficial	17 (8.3)	32 (16.0)	0.52 (0.30-0.91)	.018
Deep	4 (2.0)	4 (2.0)	0.98 (0.25-3.87)	.98
Organ space	1 (0.5)	2 (1.0)	0.49 (0.05-5.36)	.62†
Sepsis	21 (10.3)	31 (15.5)	0.66 (0.40-1.12)	.12
Bacteremia	2 (1.0)	1 (0.5)	1.96 (0.18-21.5)	.57†
Catheter line infection	2 (1.0)	0 (0.0)	—	.50†

Outcome measures	TXA (n = 204)	Placebo (n = 200)	RR (95% CI)	P
Primary end point
Health care–associated infection	43 (21.1)	63 (31.5)	0.67 (0.48-0.94)	.017
Secondary end points*	23 (11.3)	22 (11.0)	1.03 (0.59-1.78)	.93
Pneumonia
SSI	22 (10.8)	36 (18.0)	0.60 (0.37-0.98)	.039
Superficial	17 (8.3)	32 (16.0)	0.52 (0.30-0.91)	.018
Deep	4 (2.0)	4 (2.0)	0.98 (0.25-3.87)	.98
Organ space	1 (0.5)	2 (1.0)	0.49 (0.05-5.36)	.62†
Sepsis	21 (10.3)	31 (15.5)	0.66 (0.40-1.12)	.12
Bacteremia	2 (1.0)	1 (0.5)	1.96 (0.18-21.5)	.57†
Catheter line infection	2 (1.0)	0 (0.0)	—	.50†

All data are n (%). The dash indicates that the RR cannot be determined. Bold indicates significant results.

Patients could have >1 site of infection.

Fisher’s exact test.